Poland’s Mabion Gets €30m R&D Loan

Hopes To Be Among The First EU Firms With Biosimilar Rituximab

 
• By David Wallace
  
European_Investment_Bank
The European Investment Bank has lent Mabion €30m • Source: Shutterstock

More from Biosimilars

More from Products